Clinical Trial Update: Emtricitabine/Tenofovir Alafenamide Switch Study for Transgender Individuals for HIV Pre-exposure Prophylaxis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating switching to Emtricitabine/Tenofovir Alafenamide for HIV pre-exposure prophylaxis in transgender individuals on hormone therap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtricitabine/Tenofovir Alafenamide (emtricitabine/tenofovir alafenamide)

Snippet

Sponsor: University of California, San Diego | Conditions: Hiv, Hormone Therapy | Phase 4 | Status: ACTIVE_NOT_RECRUITING